- Home
- CWST vs ROIV Comparison
CWST vs ROIV Comparison
Compare CWST & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWST
- ROIV
- Stock Information
- Founded
- CWST 1975
- ROIV 2014
- Country
- CWST United States
- ROIV United Kingdom
- Employees
- CWST N/A
- ROIV N/A
- Industry
- CWST Environmental Services
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- CWST Utilities
- ROIV Health Care
- Exchange
- CWST Nasdaq
- ROIV Nasdaq
- Market Cap
- CWST 7.5B
- ROIV 8.4B
- IPO Year
- CWST 1997
- ROIV N/A
- Fundamental
- Price
- CWST $113.19
- ROIV $10.76
- Analyst Decision
- CWST Strong Buy
- ROIV Buy
- Analyst Count
- CWST 7
- ROIV 4
- Target Price
- CWST $122.67
- ROIV $17.50
- AVG Volume (30 Days)
- CWST 523.0K
- ROIV 5.8M
- Earning Date
- CWST 05-01-2025
- ROIV 05-29-2025
- Dividend Yield
- CWST N/A
- ROIV N/A
- EPS Growth
- CWST N/A
- ROIV N/A
- EPS
- CWST 0.21
- ROIV N/A
- Revenue
- CWST $1,633,376,000.00
- ROIV $122,585,000.00
- Revenue This Year
- CWST $17.45
- ROIV N/A
- Revenue Next Year
- CWST $6.94
- ROIV N/A
- P/E Ratio
- CWST $544.43
- ROIV N/A
- Revenue Growth
- CWST 21.63
- ROIV 140.04
- 52 Week Low
- CWST $88.89
- ROIV $8.73
- 52 Week High
- CWST $120.69
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- CWST 40.25
- ROIV 49.48
- Support Level
- CWST $109.12
- ROIV $10.58
- Resistance Level
- CWST $119.71
- ROIV $11.77
- Average True Range (ATR)
- CWST 3.09
- ROIV 0.34
- MACD
- CWST -1.06
- ROIV -0.08
- Stochastic Oscillator
- CWST 15.02
- ROIV 15.13
About CWST Casella Waste Systems Inc.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.